市場調査レポート

商品コード

1447815

コンパニオンアニマル用医薬品の世界市場規模、シェア、成長分析、医薬品別、動物別-産業予測、2024～2031年

Global Companion Animal Drugs Market Size, Share, Growth Analysis, By Medicine(Antibiotics, Anti-inflammatory Drugs), By Animal(Dogs, Cats) - Industry Forecast 2024-2031

出版日: 2024年02月28日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 830,828円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 971,912円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,112,996円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

コンパニオンアニマル用医薬品の世界市場規模は、2022年に139億9,000万米ドルと評価され、予測期間（2024～2031年）のCAGRは6.8%で、2023年の149億4,000万米ドルから2031年までに252億9,000万米ドルに成長する展望です。

コンパニオンアニマル用医薬品の世界市場は、世界のペット飼育世帯数の増加、ペット医療に対する意識の高まり、動物用医薬品の進歩などの要因によって、大幅な成長を遂げています。ペットの飼育数の増加は、犬、猫、その他を含むコンパニオンアニマル向けの医薬品や治療法の需要の急増につながっています。この成長を後押しする重要な要因には、予防接種や寄生虫駆除などの予防医療が重視されるようになったことや、慢性疾患に対する治療法の選択肢が広がったことが挙げられます。さらに、フレーバー錠剤や局所治療など、ドラッグデリバリー方法や製剤の革新が見られ、飼い主の投与が容易になっています。ペットの飼い主が最愛の動物の健康と幸福を優先し続ける中、コンパニオンアニマル用医薬品市場は増加傾向を続けると予想されます。このことは、製薬会社や獣医師にとって、成長し繁栄するこのセグメントのニーズを満たす機会を提供します。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

コンパニオンアニマル用医薬品の世界市場：医薬品別

市場概要
抗生物質
抗炎症薬
寄生虫駆除剤
その他

コンパニオンアニマル用医薬品の世界市場：動物別

市場概要
犬
猫
その他

コンパニオンアニマル用医薬品の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Zoetis Inc.（米国）
Elanco Animal Health Inc.（米国）
Merck & Co., Inc.（米国）
Boehringer Ingelheim（ドイツ）
Bayer AG（ドイツ）
Virbac（フランス）
Ceva Sante Animale（フランス）
Vetoquinol S.A.（フランス）
Nexvet（米国）
IDEXX Laboratories, Inc.（米国）
Biogenesis Bago（アルゼンチン）
Nutramax Laboratories, Inc.（米国）
Heska Corporation（米国）
Merial（Sanofi）（フランス）
Animalcare Group PLC（英国）
Kindred Biosciences（米国）
Norbrook Laboratories（アイルランド）
Kyoritsu Seiyaku Corporation（日本）
TVM Laboratories（フランス）
Dechra Pharmaceuticals PLC（英国）

Product Code: SQMIG35I2251

Global Companion Animal Drugs Market size was valued at USD 13.99 Billion in 2022 and is poised to grow from USD 14.94 Billion in 2023 to USD 25.29 Billion by 2031, at a CAGR of 6.8% during the forecast period (2024-2031).

The global market for companion animal drugs has seen substantial growth, driven by factors such as the increasing number of households with pets worldwide, heightened awareness of pet healthcare, and advancements in veterinary pharmaceuticals. The rise in pet ownership has led to a surge in demand for medications and treatments for companion animals, including dogs, cats, and others. Important factors propelling this growth include a greater emphasis on preventive care, such as vaccinations and parasite control, as well as an expanding range of therapeutic options for chronic conditions. Moreover, the market has witnessed innovations in drug delivery methods and formulations, such as flavoured tablets and topical treatments, making administration easier for pet owners. As pet owners continue to prioritize the health and well-being of their beloved animals, the companion animal drugs market is anticipated to continue its upward trend. This presents opportunities for pharmaceutical companies and veterinarians to meet the needs of this growing and flourishing segment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Drugs and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Companion Animal Drugs Market Segmental Analysis

The global companion animal drugs market can be segmented into several categories based on factors such as drug, animal, and region. Drug types include antibiotics, anti-inflammatory drugs, parasiticides, and others, while animal types encompass dogs, cats, and others. Geographically, the market can be divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Drivers of the Global Companion Animal Drugs Market

The companion animal drugs market is experiencing growth driven by advancements in veterinary medicine, including the development of improved diagnostics, treatments, and pharmaceuticals. These advancements have led to a broader range of treatment options and better disease management, increasing the demand for advanced companion animal medications.

The market for companion animal drugs is rapidly expanding due to shifting global preferences towards pet ownership. More individuals are adopting dogs and cats, leading to a heightened focus on pet healthcare and pharmaceuticals. This trend has resulted in increased financial investment in improving pet health. Owners, deeply connected to their pets, prioritize their well-being and are willing to invest in companion animal drugs.

Restraints in the Global Companion Animal Drugs Market

The companion animal drugs market is facing a significant challenge in the form of financial burdens associated with these medications and treatments. The high costs may discourage consumers from investing in pet health, potentially delaying or hindering market adoption. Pet owners, particularly those in low-income areas or with limited budgets, may find the expenses of these costly healthcare options for their animals to be prohibitive.

Regulatory bodies tightly control the companion animal drugs market. Compliance with strict rules and obtaining approvals for production and distribution can pose challenges for market players. These stringent requirements can consume a significant amount of time, resulting in a lengthy and expensive process overall. The demanding task of securing approvals and maintaining compliance during development can be arduous, potentially limiting new product entries and causing delays in innovation, which could have negative impacts on the market.

Market Trends of the Global Companion Animal Drugs Market

Digital Health Innovations: The field of veterinary medicine is undergoing changes with the adoption of data analytics and other digital technologies. Wearable devices, telehealth services, and mobile apps have become integrated into veterinary care. These advancements enable pet owners to remotely monitor their pets' health indicators and facilitate communication with consulting veterinarians. Additionally, these technologies aid in managing medication prescriptions with precision.

Emergence of Specialty and Personalized Medications: The companion animal drug market has undergone a significant shift as pet owners increasingly seek personalized and advanced medications for their cats and dogs. Pharmaceutical companies and veterinarians are adapting to this trend by tailoring treatments to suit the diverse health conditions of various animal breeds and sizes. Customized medications are viewed as a potential solution for more effective and precise therapies, with accessibility growing to meet the rising demand.

Focus on Preventive Care: Another notable trend influencing the pet drug industry is the increased emphasis on preventive care for pets. In response to this trend, market players are emphasizing the development and promotion of various products, including wellness and parasite control products, as well as advanced vaccines. Pet owners are prioritizing the health and overall well-being of their pets, leading to a growing demand for preventive medicines.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Companion Animal Drugs Market by Medicine

Market Overview
Antibiotics
Anti-inflammatory Drugs
Parasiticides
and others

Global Companion Animal Drugs Market by Animal

Market Overview
Dogs
Cats
and others

Global Companion Animal Drugs Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Zoetis Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexvet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEXX Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis Bago (Argentina)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutramax Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merial (Sanofi) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Animalcare Group PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kindred Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norbrook Laboratories (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyoritsu Seiyaku Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TVM Laboratories (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dechra Pharmaceuticals PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments